Clinical Trials in Austin

Showing 12221-12240 of 13,060 trials

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

NCT00095381

BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. The Phase II trial is designed to study the effectiveness of BCX-1777 in treating patients who have recurrent or refractory advanced T-cell leukemia. Patients will receive an infusion of BCX-1777 on days 1-5. Treatment may be repeated every week for up to six courses. Patients are not required to be hospitalized for the administration of BCX-1777. Some patients may continue to receive an infusion of BCX-1777 twice a week for 6 weeks.

Leukemia, T-Cell

BioCryst Pharmaceuticals20 participantsStarted Mar 2004

Los Angeles, California, United States • Palo Alto, California, United States • Denver, Colorado, United States +21 more locations

COMPLETEDPhase 362 miles

Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.

NCT00636116

The purpose of this study is to establish if F(ab)2 antivenom (Anavip) is safe for crotalinae envenomation. Confirm its effectiveness in preventing the occurrence of delayed coagulopathies and compare the safety and efficacy with Fab antivenom (CroFab) in patients with Crotalinae envenomation.

Snake Bite

Instituto Bioclon S.A. de C.V.121 participantsStarted May 2008

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +15 more locations

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.

Find Trials by Condition in Austin

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

Study of Oral AEE788 in Adults With Advanced Cancer

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency

The Simple ECG Monitoring Trial (Comparison of a Novel Recording System With a Standard Holter Monitor)